Elyse Stock, Chief Medical Officer at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 17,700 shares at $45.07 ($798K) on 2019-10-18, disclosed to the SEC on 2019-10-25.
Open-market sale of $798k BHVN by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BHVN | SELL | 2019-10-17 | $36K | — | Filing → |